Identifying brain markers for problematic cannabis use
Connectome-based neuromarkers of problem cannabis use
This study is looking at how certain brain features might help us understand why some teens and young adults have problems with cannabis use, so we can find ways to help those at risk before issues arise.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10891574 on NIH RePORTER |
What this research studies
This research investigates the brain-based risk factors associated with problematic cannabis use, particularly in adolescents and young adults. By utilizing advanced neuroimaging techniques and machine learning, the study aims to identify specific neural networks that predict the likelihood of developing issues related to cannabis use. The research combines data from large-scale studies, including a nationally representative sample of children, to understand how these brain markers develop over time and their relationship with other addiction risk factors. This approach seeks to enhance early intervention strategies for those at risk.
Who could benefit from this research
Good fit: Ideal candidates for this research include adolescents and young adults, particularly those with a family history of substance use or exposure to early adversity.
Not a fit: Patients who do not use cannabis or have no history of substance use issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and intervention strategies for individuals at risk of cannabis-related harm.
How similar studies have performed: Previous research has shown promise in identifying brain markers for various substance use disorders, suggesting that this approach may yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Lichenstein, Sarah D. — Yale University
- Study coordinator: Lichenstein, Sarah D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.